Center-Authored Papers

Filters: Author is Clendenning, Mark  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I et al..  2012.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(9):958-64. Abstract
Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H et al..  2016.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.. International journal of cancer. 139(7):1557-1563. Abstract
Win AK, Reece JC, Buchanan DD, Clendenning M, Young JP, Cleary SP, Kim H, Cotterchio M, Dowty JG, MacInnis RJ et al..  2015.  Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.. Familial cancer. 14(4):575-83. Abstract
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG et al..  2014.  Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, with and without a Family History of Cancer.. Gastroenterology. Abstract
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M et al..  2015.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.. Gut. 64(1):101-10. Abstract
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ et al..  2016.  Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Walsh MD, Buchanan DD, Cummings MC, Pearson S-A, Arnold ST, Clendenning M, Walters R, McKeone DM, Spurdle AB, Hopper JL et al..  2010.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(7):2214-24. Abstract
T
Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, Parsons MT, Michael D, Gallinger S, Haile RW et al..  2012.  A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry.. Human mutation. Abstract
S
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
R
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S et al..  2016.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.. BMJ open. 6(2):e010293. Abstract
Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD et al..  2011.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).. Familial cancer. 10(2):245-54. Abstract
O
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
L
Lindor NM, Larson MC, Derycke MS, McDonnell SK, Baheti S, Fogarty ZC, Win AK, Potter JD, Buchanan DD, Clendenning M et al..  2016.  Germline miRNA DNA Variants and the Risk of Colorectal Cancer by Subtype.. Genes, chromosomes & cancer. Abstract
G
Goodenberger MKL, Thomas BC, Riegert-Johnson D, Boland RC, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK et al..  2016.  PMS2 monoallelic mutation carriers: the known unknown.. Genetics in medicine : official journal of the American College of Medical Genetics. 18(1):13-19. Abstract
D
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S et al..  2013.  Cancer Risks for MLH1 and MSH2 Mutation Carriers.. Human mutation. 34(3):490-7. Abstract
Derycke MS, Gunawardena SR, Middha S, Asmann YA, Schaid DJ, McDonnell SK, Riska SM, Eckloff BW, Cunningham JM, Fridley BL et al..  2013.  Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Dashti GS, Buchanan DD, Jayasekara H, Ouakrim DA, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S et al..  2016.  Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW et al..  2015.  Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.. JAMA. 314(1):61-71. Abstract
C
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, Le Marchand L, Haile R, Gallinger S et al..  2013.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial cancer. 12(3):563-6. Abstract
Chau R, Dashti SG, Ouakrim DA, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA et al..  2016.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.. International journal of epidemiology. 45(3):940-953. Abstract
B
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler BN, Pearson S-A, Macrae F, Parry S, Arnold J et al..  2013.  Family History of Colorectal Cancer in BRAF p.V600E mutated Colorectal Cancer Cases.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract